The control of hypertension: A therapeutic breakthrough

Norman M Kaplan

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

The developments responsible for this therapeutic breakthrough can be considered in this sequence: the recognition of the importance of even mild hypertension as a cardiovascular risk factor, the unraveling of enough of the pathophysiology of hypertension to rationalize approaches toward its treatment, the demonstration of the value of therapy in reducing the complications that arise, starting with the most severe forms of the disease and proceeding down to the mildest, and the avalability of both nondrug and drug therapies that are effecive and convenient, making long-term control possible in nearly all cases. These new agents offer the promise of more precise corrective manipulation of the hemodynamic aberrations responsible for hypertension. But, without identification of a single, specific mechanism responsible for hypertension in an individual, exact correction may be impossible. Though current therapy is largely empiric, it often succeeds in reversing the underlying hemodynamic defects while, most important, effectively lowering the blood pressure.

Original languageEnglish (US)
Pages (from-to)537-545
Number of pages9
JournalAmerican Scientist
Volume68
Issue number5
StatePublished - 1980

Fingerprint

Hemodynamics
hypertension
Hypertension
Drug therapy
therapeutics
Blood pressure
hemodynamics
Aberrations
Demonstrations
Defects
Therapeutics
pathophysiology
drug therapy
blood pressure
risk factors
Blood Pressure
Drug Therapy

ASJC Scopus subject areas

  • General
  • Agricultural and Biological Sciences(all)
  • Materials Science (miscellaneous)

Cite this

The control of hypertension : A therapeutic breakthrough. / Kaplan, Norman M.

In: American Scientist, Vol. 68, No. 5, 1980, p. 537-545.

Research output: Contribution to journalArticle

Kaplan, NM 1980, 'The control of hypertension: A therapeutic breakthrough', American Scientist, vol. 68, no. 5, pp. 537-545.
Kaplan, Norman M. / The control of hypertension : A therapeutic breakthrough. In: American Scientist. 1980 ; Vol. 68, No. 5. pp. 537-545.
@article{a7b6f59916bf46b09728b313ed878d44,
title = "The control of hypertension: A therapeutic breakthrough",
abstract = "The developments responsible for this therapeutic breakthrough can be considered in this sequence: the recognition of the importance of even mild hypertension as a cardiovascular risk factor, the unraveling of enough of the pathophysiology of hypertension to rationalize approaches toward its treatment, the demonstration of the value of therapy in reducing the complications that arise, starting with the most severe forms of the disease and proceeding down to the mildest, and the avalability of both nondrug and drug therapies that are effecive and convenient, making long-term control possible in nearly all cases. These new agents offer the promise of more precise corrective manipulation of the hemodynamic aberrations responsible for hypertension. But, without identification of a single, specific mechanism responsible for hypertension in an individual, exact correction may be impossible. Though current therapy is largely empiric, it often succeeds in reversing the underlying hemodynamic defects while, most important, effectively lowering the blood pressure.",
author = "Kaplan, {Norman M}",
year = "1980",
language = "English (US)",
volume = "68",
pages = "537--545",
journal = "American Scientist",
issn = "0003-0996",
publisher = "Sigma Xi, Scientific Research Society",
number = "5",

}

TY - JOUR

T1 - The control of hypertension

T2 - A therapeutic breakthrough

AU - Kaplan, Norman M

PY - 1980

Y1 - 1980

N2 - The developments responsible for this therapeutic breakthrough can be considered in this sequence: the recognition of the importance of even mild hypertension as a cardiovascular risk factor, the unraveling of enough of the pathophysiology of hypertension to rationalize approaches toward its treatment, the demonstration of the value of therapy in reducing the complications that arise, starting with the most severe forms of the disease and proceeding down to the mildest, and the avalability of both nondrug and drug therapies that are effecive and convenient, making long-term control possible in nearly all cases. These new agents offer the promise of more precise corrective manipulation of the hemodynamic aberrations responsible for hypertension. But, without identification of a single, specific mechanism responsible for hypertension in an individual, exact correction may be impossible. Though current therapy is largely empiric, it often succeeds in reversing the underlying hemodynamic defects while, most important, effectively lowering the blood pressure.

AB - The developments responsible for this therapeutic breakthrough can be considered in this sequence: the recognition of the importance of even mild hypertension as a cardiovascular risk factor, the unraveling of enough of the pathophysiology of hypertension to rationalize approaches toward its treatment, the demonstration of the value of therapy in reducing the complications that arise, starting with the most severe forms of the disease and proceeding down to the mildest, and the avalability of both nondrug and drug therapies that are effecive and convenient, making long-term control possible in nearly all cases. These new agents offer the promise of more precise corrective manipulation of the hemodynamic aberrations responsible for hypertension. But, without identification of a single, specific mechanism responsible for hypertension in an individual, exact correction may be impossible. Though current therapy is largely empiric, it often succeeds in reversing the underlying hemodynamic defects while, most important, effectively lowering the blood pressure.

UR - http://www.scopus.com/inward/record.url?scp=0019137657&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019137657&partnerID=8YFLogxK

M3 - Article

C2 - 6999952

AN - SCOPUS:0019137657

VL - 68

SP - 537

EP - 545

JO - American Scientist

JF - American Scientist

SN - 0003-0996

IS - 5

ER -